ArticleFrontiers in immunology2026

Thromboembolic adverse events associated with TPO-RA in ITP treatment: a pharmacovigilance analysis of the FDA Adverse Event Reporting System.

Zhen Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.